Successful Use of Recombinant Factor VIIa (NovoSeven) During Cardiac Surgery in a Pediatric Patient with Glanzmann Thrombasthenia

[1]  R. Gill,et al.  New alternatives for control of severe cardiac surgical bleeding , 2004 .

[2]  M. Morfini,et al.  Relationship between Factor VII Activity and Clinical Efficacy of Recombinant Factor VIIa Given by Continuous Infusion to Patients with Factor VIII Inhibitors , 2001, Thrombosis and Haemostasis.

[3]  P. Collins,et al.  Elective Surgery on Factor VIII Inhibitor Patients Using Continuous Infusion of Recombinant Activated Factor VII , 2001, Thrombosis and Haemostasis.

[4]  G. Dolan,et al.  Thalidomide and low‐dose dexamethasone in myeloma treatment , 2001, British journal of haematology.

[5]  S. Rangarajan,et al.  Use of recombinant factor VIIa for post‐operative haemorrhage in a patient with Glanzmann's thrombasthenia and human leucocyte antigen antibodies , 2001, British journal of haematology.

[6]  S. Sheth,et al.  Heart transplant in a factor VIII‐deficient patient with a high‐titre inhibitor: perioperative management using high‐dose continuous infusion factor VIII and recombinant factor VIIa , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

[7]  G. Bray,et al.  Relationship between Factor VIII Mutation Type and Inhibitor Development in a Cohort of Previously Untreated Patients Treated with Recombinant Factor VIII (Recombinate™) , 2000, Thrombosis and Haemostasis.

[8]  P. Nurden,et al.  Use of Recombinant Factor VIIa in 3 Patients with Inherited Type I Glanzmann’s Thrombasthenia Undergoing Invasive Procedures , 2000, Thrombosis and Haemostasis.

[9]  M. Al Douri,et al.  Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery , 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[10]  Ü. Koçak,et al.  The effect of steroid and intravenous immunoglobulin on thrombopoietin levels in pediatric patients with immune thrombocytopenic purpura. , 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[11]  U. Hedner.  Recombinant Coagulation Factor VIIa: From the Concept to Clinical Application in Hemophilia Treatment in 2000 , 2000, Seminars in thrombosis and hemostasis.

[12]  M. Poon,et al.  Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. , 1999, Blood.

[13]  A D Shapiro,et al.  Prospective, Randomised Trial of Two Doses of rFVIIa (NovoSeven) in Haemophilia Patients with Inhibitors Undergoing Surgery , 1998, Thrombosis and Haemostasis.

[14]  C. Kessler,et al.  Safety, efficacy and lessons from continuous infusion with rFVIIa , 1998 .

[15]  S. Schulman.  Safety, efficacy and lessons from continuous infusion with rFVIIa. rFVIIa-CI Group. , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

[16]  P. Steg,et al.  A Patient with Glanzmann Thrombasthenia and Epistaxis Successfully Treated with Recombinant Factor Vila , 1996, Thrombosis and Haemostasis.

[17]  L. Tengborn,et al.  A Patient with Glanzmann Thrombasthenia and Epistaxis Successfully Treated with Recombinant Factor Vila , 1996, Thrombosis and Haemostasis.